Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
Lilly drops another gene therapy trial from $1B Prevail buyout
The termination further dents the drugmaker’s chances of delivering a return on its investment in Prevail Therapeutics.
Nick Paul Taylor
Aug 5, 2026 9:10am
J&J axes eye disease gene therapy after key phase 2b readout
Jul 15, 2026 10:26am
FDA gene therapy regulator steps down from leadership role
Jun 30, 2026 10:36am
UniQure stock surges after FDA U-turn clears path to filing
Jun 17, 2026 9:10am
Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B
Jun 3, 2026 7:00am
Regenxbio reaps pivotal win for Duchenne gene therapy
May 14, 2026 7:25am
